MRV Engenharia e Participações S.A (MRVE3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 8.230 |
|---|---|
| 52-week range | 4.200 – 10.530 |
| Return, 1 month / 3 months | +57.1% / +87.5% |
| Return, 1 year / 3 years | +17.2% / −4.0% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 53.6% |
| Worst drawdown (1 year) | -59.7% |
| Average daily value traded | 80.66M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MRV Engenharia e Participações S.A. is a Brazilian homebuilder based in Belo Horizonte that develops and constructs residential apartment buildings, concentrating on affordable housing for lower-income families. Much of its work is delivered through government-backed housing programmes that help buyers finance their homes. The company handles land acquisition, development, construction and the sale of units to individual buyers, and it also operates in other Latin American markets through its residential building business.
MRV Engenharia e Participações S.A trades under the code MRVE3 on the B3 Stock Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MRV Engenharia e Participações S.A (MRVE3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 8.230 on 23 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 768 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.2% and over the last three months it rose 87.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 24.0% | ||
| From 52-week high | -21.1% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 87.5% | ||
| 6-month return | 10.3% | ||
| 12-month return, skipping the last month | -25.4% | ||
| Stability (higher is calmer) | 18 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -59.7% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 80.66M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +14.0% |
|---|---|
| 1 month | +57.1% |
| 3 months | +87.5% |
| 6 months | +10.3% |
| 1 year | +17.2% |
| 3 years | −4.0% |
| 5 years | −17.6% |
Signals
| 50-day / 200-day average | 5.614 / 6.636 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.515 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Sep 2022 | BRL 0.1978 |
| 23 Jun 2022 | BRL 0.1978 |
| 6 Dec 2021 | BRL 0.1624 |
| 29 Apr 2021 | BRL 0.2706 |
| 18 Jan 2021 | BRL 0.2071 |
| 13 Oct 2020 | BRL 0.3701 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.